Lincoln Pharmaceuticals Limited — Others, 07-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Lincoln Pharmaceuticals has submitted a confirmation certificate regarding the dematerialization of securities for the quarter ended December 31, 2024, as required by SEBI regulations. This confirmation indicates that all securities received for dematerialization have been processed, with listings appropriately updated on the stock exchanges.

The implications suggest streamlined operations for the company’s share management, enhancing investor confidence through improved efficiency in their registration processes. This update could contribute to a positive outlook for shareholders, reflecting the company’s adherence to regulatory compliance and operational transparency.